New EEG electrode set for fast and easy measurement of brain function abnormalities
News Sep 24, 2014
A new, easy-to-use EEG electrode set for the measurement of the electrical activity of the brain was developed in a recent study completed at the University of Eastern Finland. The solutions developed in the PhD study of Pasi Lepola, MSc, make it possible to attach the electrode set on the patient quickly, resulting in reliable results without any special treatment of the skin. As EEG measurements in emergency care are often performed in challenging conditions, the design of the electrode set pays particular attention to the reduction of electromagnetic interference from external sources.
EEG measurements can be used to detect such abnormalities in the electrical activity of the brain that require immediate treatment. These abnormalities are often indications of severe brain damage, cerebral infarction, cerebral haemorrhage, poisoning, or unspecified disturbed levels of consciousness. One of the most serious brain function abnormalities is a prolonged epileptic seizure, status epilepticus, which is impossible to diagnose without an EEG measurement. In many cases, a rapidly performed EEG measurement and the start of a proper treatment significantly reduces the need for aftercare and rehabilitation. This, in turn, drastically improves the cost-effectiveness of the treatment chain.
Although the benefits of EEG measurements are indisputable, they remain underused in acute and emergency care. A significant reason for this is the fact that the electrode sets available on the markets are difficult to attach on the patient, and their use requires special skills and constant training. This new type of an electrode set is expected to provide solutions for making EEG measurements feasible at as an early stage as possible.
The EEG electrode set was produced using screen printing technology, in which silver ink was used to print the conductors and measurement electrodes on a flexible polyester film. The EEG electrode set consists of 16 hydrogel-coated electrodes which, unlike in the traditional method, are placed on the hair-free areas of the patient's head, making it easy to attach. The new EEG electrode set significantly speeds up the measurement process because there is no need to scrape the patient's skin or to use any separate gels. As the electrode set is flexible and solid, the electrodes get automatically placed in their correct places. Furthermore, there is no need to move the patient's head when putting on the EEG electrode set, which is especially important in patients possibly suffering from a neck or skull injury. Due to the fact that the disposable electrode set is easy and fast to use, it is particularly well-suited to be used in emergency care, in ambulances and even in field conditions. Thanks to the materials used, the electrode set does not interfere with any magnetic resonance or computed tomography imaging the patient may undergo.
The electrode set is easy to use and it is suitable for, for example, quick measurements in emergency care and long-term monitoring taking place within hospitals. Credit: Pasi Lepola
The performance of the electrode set was tested by using various electrical tests, on several volunteers, and in real patient cases. The results were compared to those obtained by traditional EEG methods.
The PhD study also focused on the use of screen printing technology solutions to protect electrodes against electromagnetic interference. The silver or graphite shielding layer printed to the outer edge of the electrode set was discovered to significantly reduce external interference on the EEG signal. This shielding layer can be easily and cost-efficiently introduced to all measurement electrodes produced with similar methods. Protecting the electrode with a shielding layer is beneficial when measuring weak signals in conditions that contain external interference.
Note: Material may have been edited for length and content. For further information, please contact the cited source.
Combination Chemotherapy Could Significantly Improve Deadly Brain Tumor TreatmentNews
A team led by Massachusetts General Hospital (MGH) investigators has found that adding the chemotherapy drug hydroxyurea to the current chemotherapy protocol for glioblastoma significantly increased survival in animal models.READ MORE
Purine Synthesis in Neuron-Like Cells InvestigatedNews
Neuron-like cells created from a readily available cell line have allowed researchers to investigate how the human brain makes a metabolic building block essential for the survival of all living organisms.READ MORE
All in a Droplet: Atomic Resolution of ALS Protein ResolvedNews
Researchers have described atom-by-atom changes in a family of proteins linked to amyotrophic lateral sclerosis (ALS), a group of brain disorders known as frontotemporal dementia and degenerative diseases of muscle and bone.READ MORE